EQUINE VACCINES

Brand Owner (click to sort) Address Description
EQUI-JEC BOEHRINGER INGELHEIM VETMEDICA, INC. 2621 North Belt Highway St. Joseph MO 645062002 equine vaccines;EQUI-JEC; EQUINE-INJECTION;
EQUILOID INNOVATOR ZOETIS SERVICES 10 Sylvan Way Parsippany NJ 07054 Equine vaccines;
EQUIVAC INNOVATOR ZOETIS SERVICES 10 Sylvan Way Parsippany NJ 07054 equine vaccines;EQUINE VACCINES INNOVATOR;
FLUVAC INNOVATOR ZOETIS SERVICES 10 Sylvan Way Parsippany NJ 07054 Equine vaccines;
NORTH AMERICAN EQUINE E159 BOEHRINGER INGELHEIM VETMEDICA GmbH 173 Binger Strasse Ingelheim 55218 Germany equine vaccines;NORTH AMERICAN EQUINE E 159;NORTH AMERICAN EQUINE;
TRIPLE-E FT Wyeth Holdings Corporation 235 East 42nd Street New York NY 10017 equine vaccines;TRIPLE EFFECT;
TRIPLE-E T INNOVATOR ZOETIS SERVICES 10 Sylvan Way Parsippany NJ 07054 Equine vaccines;
WEST NILE-INNOVATOR ZOETIS SERVICES 10 Sylvan Way Parsippany NJ 07054 EQUINE VACCINES;WEST NILE INNOVATOR;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. This invention relates to the development of a mammalian expression vector, under which expression of the structural genes of western equine encephalitis virus have been placed under the control of an eucaryotic promoter. When the recombinant vector is administered to mammalian cell culture or using a cell-free transcription/translation system, in vitro, authentic structural proteins of western equine encephalitis virus are produced as verified by reactivity with monoclonal antibodies developed to western equine encephalitis virus. When the recombinant DNA molecule is administered in vivo, a protective immune response is induced, thereby enhancing protection of the individual against subsequent infection by western equine encephalitis virus. In a similar manner, DNA vaccines to related alphaviruses (Venezuelan and eastern equine encephalitis viruses) could also be developed.